Evidence map›Paper›PMID 28677007›Full record

ReviewMammalian genome : official journal of the International Mammalian Genome Society2017

Modeling human disease in rodents by CRISPR/Cas9 genome editing.

Marie-Christine Birling, Yann Herault, Guillaume Pavlovic

Abstract readReview
In one paragraph

Review in Mammalian genome : official journal of the International Mammalian Genome Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. A Human HomozygousGenes · 2024
    Article
  3. CRISMERE Chromosome Engineering in Mouse and Rat.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  4. Review
  5. Rs1hGene therapy · 2022
    Article
  6. Article
  7. Review
  8. Sensory Innervation of the Larynx and the Search for Mucosal Mechanoreceptors.Journal of speech, language, and hearing research : JSLHR · 2021
    Article
  9. CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Review
  10. Review
  11. Review
  12. Cyclin-dependent kinases and rare developmental disorders.Orphanet journal of rare diseases · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. PATHBIO: an international training program for precision mouse phenotyping.Mammalian genome : official journal of the International Mammalian Genome Society · 2020
    Article
  17. Review
  18. Review
  19. Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marie-Christine BirlingCELPHEDIA, PHENOMIN, Institut Clinique de la Souris (ICS), CNRS, INSERM, University of Strasbourg, 1 rue Laurent Fries, 67404, Illkirch, France. birlingm@igbmc.fr.
Yann HeraultCELPHEDIA, PHENOMIN, Institut Clinique de la Souris (ICS), CNRS, INSERM, University of Strasbourg, 1 rue Laurent Fries, 67404, Illkirch, France.
Guillaume PavlovicCELPHEDIA, PHENOMIN, Institut Clinique de la Souris (ICS), CNRS, INSERM, University of Strasbourg, 1 rue Laurent Fries, 67404, Illkirch, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modeling human disease has proven to be a challenge for the scientific community. For years, generating an animal model was complicated and restricted to very few species. With the rise of CRISPR/Cas9, it is now possible to generate more or less any animal model. In this review, we will show how this technology is and will change our way to obtain relevant disease animal models and how it should impact human health.

Indexed as

CRISPR-Cas SystemsGene EditingGenetic Predisposition to DiseaseModels, BiologicalAnimalsAnimals, Genetically ModifiedDisease Models, AnimalGenetic Association StudiesGenetic TherapyGenetic VariationGenomicsHumansMiceMultifactorial InheritanceOpen Reading FramesPrecision MedicineRegulatory Sequences, Ribonucleic AcidRNA, Untranslated

Identifiers

PMID28677007
PMCPMC5569124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.